COVID-19 の患者でニルマトレルビル/リトナビールを併用した時のヴォリコナゾールの血濃度: 多中心の遡及研究
Hao Shi1, Xuan Zhang2, Qihui Kong3
1Department of Pharmacy, Shaoxing Campus, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Shaoxing, China.
Frontiers in pharmacology
|September 2, 2025
まとめ
COVID-19 に対してニルマトレルビル/リトナビールとヴォリコナゾールの併用は可能である. 潜在的に超治療的濃度があるため,ヴォリコナゾールの濃度を注意深くモニタリングすることが不可欠であり,さらなる投与試験の必要性を示しています.
科学分野:
- 薬理学について
- 感染症
- 薬物相互作用
背景:
- ニルマトレルビル/ リトナビルは,薬物相互作用 (DDI) により,一般的に併用が禁忌です.
- 新しいデータによると,DDIは複雑で,同時に使用できる可能性がある.
研究 の 目的:
- COVID-19患者におけるニルマトレルビル/リトナビルとヴォリコナゾールの併用の可能性と安全性を調査する.
- 両方の薬を服用している患者におけるヴォリコナゾールの血濃度を分析する.
主な方法:
- 多中心の遡及研究では,2023年以降のCOVID-19入院患者が両方の薬を服用した.
- 病院の情報システムから,ヴォリコナゾールの血値と薬剤記録を分析した.
主要な成果:
- 13人の患者と16人のヴォリコナゾールの最低濃度が分析されました.
- 患者の50%が治療用ヴォリコナゾール濃度を示した.
- 50%は治療範囲外で,87. 5%は超治療的でした.
結論:
- ニルマトレルビル/ リトナビルとヴォリコナゾルの併用は,特定のケースでは可能である.
- ニルマトレルビール/ リトナビールと併用する際に最適なヴォリコナゾールの投与戦略を確立するには,さらなる研究が必要である.
関連する概念動画
Subviral Agents
111
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
111
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Drug Distribution: Plasma Protein Binding
6.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
6.6K
Antimicrobial Effectiveness
156
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156
Time Course of Drug Effect
2.2K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.2K
Hepatic Drug Clearance: Effect of Protein Binding
284
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
284


